<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li X</submitter><funding>Science and Technology Commission of Shanghai Municipality</funding><funding>National Natural Science Foundation of China</funding><pagination>950345</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9478117</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13</volume><pubmed_abstract>Due to the lack of symptoms and detection biomarkers at the early stage, most patients with ovarian cancer (OC) are diagnosed at an advanced stage and often face chemoresistance and relapse. Hence, defining detection biomarkers and mechanisms of chemoresistance is imperative. A previous report of a cDNA microarray analysis shows a potential association of carnitine O-octanoyltransferase (CROT) with taxane resistance but the biological function of CROT in OC remains unknown. The current study explored the function and regulatory mechanism of CROT on cellular behavior and paclitaxel (PTX)-resistance in OC. We found that CROT was downregulated in OC tissues and PTX-resistant cells. Furthermore, CROT expression was negatively correlated with the prognosis of OC patients. Overexpression of CROT</pubmed_abstract><journal>Frontiers in endocrinology</journal><pubmed_title>The miR-33a-5p/CROT axis mediates ovarian cancer cell behaviors and chemoresistance &lt;i>via&lt;/i> the regulation of the TGF-β signal pathway.</pubmed_title><pmcid>PMC9478117</pmcid><funding_grant_id>81872121</funding_grant_id><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Guan W</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Wang F</pubmed_authors><pubmed_authors>Gao X</pubmed_authors><pubmed_authors>Xu X</pubmed_authors><pubmed_authors>Xu G</pubmed_authors><pubmed_authors>Yuan J</pubmed_authors></additional><is_claimable>false</is_claimable><name>The miR-33a-5p/CROT axis mediates ovarian cancer cell behaviors and chemoresistance &lt;i>via&lt;/i> the regulation of the TGF-β signal pathway.</name><description>Due to the lack of symptoms and detection biomarkers at the early stage, most patients with ovarian cancer (OC) are diagnosed at an advanced stage and often face chemoresistance and relapse. Hence, defining detection biomarkers and mechanisms of chemoresistance is imperative. A previous report of a cDNA microarray analysis shows a potential association of carnitine O-octanoyltransferase (CROT) with taxane resistance but the biological function of CROT in OC remains unknown. The current study explored the function and regulatory mechanism of CROT on cellular behavior and paclitaxel (PTX)-resistance in OC. We found that CROT was downregulated in OC tissues and PTX-resistant cells. Furthermore, CROT expression was negatively correlated with the prognosis of OC patients. Overexpression of CROT</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2026-05-28T05:44:06.299Z</modification><creation>2025-02-19T04:39:01.081Z</creation></dates><accession>S-EPMC9478117</accession><cross_references><pubmed>36120434</pubmed><doi>10.3389/fendo.2022.950345</doi></cross_references></HashMap>